Atilla Soran, MD, MPH

home / authors / atilla-soran-md-mph

Articles

59 Are Choosing Wisely Guidelines Applicable to Patients With a High Ki-67 Proliferation Index and Magee Equation Score?

59 Are Choosing Wisely Guidelines Applicable to Patients With a High Ki-67 Proliferation Index and Magee Equation Score?

Leslie Elmore;Neil Carleton;Michael S. Cowher;Rohit Bhargava;Emilia Diego;Kristin Lupinacci;Meaghan Marley;Qurat Ul Ain Sabih;Atilla Soran, MD, MPH;Jennifer Steiman;Ronald Johnson;Erin Bayley;Priscilla F. Mcauliffe, MD, PhD
May 17th 2025
90 Contralateral Risk Reduction Mastectomy in Patients With Unilateral Breast Cancer: A Multinational and Multidisciplinary Survey—Physicians’ Perspective

90 Contralateral Risk Reduction Mastectomy in Patients With Unilateral Breast Cancer: A Multinational and Multidisciplinary Survey—Physicians’ Perspective

Atilla Soran, MD, MPH;Kazim Senol;Schlomo Schneebaum;Shigeru Imoto;Carole Mathelin;Alexander Mundinger;Meltem Selam;Vahit Ozmen
April 21st 2025
91 Adverse Effects and Financial Burden of Radiation Therapy in Patients With T3N0M0 Luminal Breast Cancer

91 Adverse Effects and Financial Burden of Radiation Therapy in Patients With T3N0M0 Luminal Breast Cancer

Zeynep Ozlem Soran;Allison Brophy;Lily Kass;Berkay Demirors;Hayeon Kim;Atilla Soran, MD, MPH;John Austin Vargo;Parul Barry
April 20th 2025
43 Factors Affecting Survival in Solitary Bone-Only De Novo Stage IV Metastatic Breast Cancer

43 Factors Affecting Survival in Solitary Bone-Only De Novo Stage IV Metastatic Breast Cancer

Kazim Senol;Aykut Soyder;Ahmet Dag;Didem Can Trabulus;Ahmet Bilici;Mutlu Dogan;Hasan Karanlık;Serdar Ozbas;Atilla Soran, MD, MPH
April 26th 2023
43 Early Detection of Breast Cancer–Related Lymphedema: Accuracy of Indocyanine Green Lymphography Compared With Bioimpedance Spectroscopy and Symptoms

43 Early Detection of Breast Cancer–Related Lymphedema: Accuracy of Indocyanine Green Lymphography Compared With Bioimpedance Spectroscopy and Symptoms

Atilla Soran, MD, MPH;Fuat B. Bengur;Wendy Rodriguez;Efe Sezgin
May 6th 2022
Site Logo

Lymphedema Prevention and Early Intervention: A Worthy Goal

Atilla Soran, MD, MPH;David N. Finegold, MD;Adam M. Brufsky, MD, PhD
March 12th 2012

The etiology and risk factors of breast cancer–related lymphedema (BCRL) are multifactorial and not fully understood.

Latest Updated Articles

Treosulfan plus fludarabine is now approved by the FDA as an injection for allo-HSCT conditioning for patients with AML or MDS.
Published: January 24th 2025 | Updated: February 6th 2025
FDA Approves Treosulfan Combo Injection for HSCT Conditioning in AML/MDS
Non–clear Cell RCC: First-Line Treatment Options and Guideline Updates
Published: September 13th 2024 | Updated: November 25th 2024
Non–clear Cell RCC: First-Line Treatment Options and Guideline Updates
NSABP B-42 trial results show that the assay was predictive of extended letrozole therapy response, identifying a patient subset with improved outcomes.
Published: August 9th 2024 | Updated: August 14th 2024
Gene Assay May Predict Extended Letrozole Benefits in Breast Cancer Subsets
OS Prolonged With Perioperative Chemo Vs Neoadjuvant CRT in Esophageal Cancer
Published: June 2nd 2024 | Updated: June 3rd 2024
OS Prolonged With Perioperative Chemo Vs Neoadjuvant CRT in Esophageal Cancer
Data from the CheckMate-67T trial support the biologics license application for subcutaneous nivolumab in multiple solid tumors.
Published: May 6th 2024 | Updated: May 21st 2024
FDA Accepts BLA for Subcutaneous Nivolumab in Solid Tumor Indications
Photosensitive Facial Rash Depicted Along with Polyarticular Arthralgias
Published: April 30th 2011 | Updated: July 26th 2025
Photosensitive Facial Rash Depicted Along with Polyarticular Arthralgias